These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11358701)

  • 1. Early medical abortion with methotrexate and misoprostol: outcomes and satisfaction among women aged 15-21 years.
    Borgatta L; French A; Vragovic O; Burnhill MS
    J Pediatr Adolesc Gynecol; 2001 Feb; 14(1):9-16. PubMed ID: 11358701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early medical abortion with methotrexate. Outcome and satisfaction among women aged 15-20 years.
    Borgatta L; French A; Vragovic O; Burnhill M
    J Pediatr Adolesc Gynecol; 2000 May; 13(2):87-8. PubMed ID: 10869971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.
    Creinin MD; Vittinghoff E; Keder L; Darney PD; Tiller G
    Contraception; 1996 Jun; 53(6):321-7. PubMed ID: 8773418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of methotrexate and misoprostol for early abortion.
    Ozeren S; Corakçi A; Yücesoy I; Mercan R; Arslan A; Erhan G
    Gynecol Obstet Invest; 1997; 44(2):112-4. PubMed ID: 9286724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early medical abortion with methotrexate and misoprostol.
    Borgatta L; Burnhill MS; Tyson J; Leonhardt KK; Hausknecht RU; Haskell S
    Obstet Gynecol; 2001 Jan; 97(1):11-6. PubMed ID: 11152899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instituting medical abortion services: changes in outcome and acceptability related to provider experience.
    Borgatta L; Burnhill M; Haskell S; Nichols M; Leonhardt K
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):173-6. PubMed ID: 10846332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing abortion induced with methotrexate and misoprostol to methotrexate alone.
    Wiebe ER
    Contraception; 1999 Jan; 59(1):7-10. PubMed ID: 10342080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate. A single agent for early abortion.
    Schaff EA; Penmetsa U; Eisinger SH; Franks P
    J Reprod Med; 1997 Jan; 42(1):56-60. PubMed ID: 9018647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical abortion alternatives to mifepristone.
    Creinin MD; Pymar HC
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):127-32, 150. PubMed ID: 10846321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
    Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion.
    Creinin MD; Carbonell JL; Schwartz JL; Varela L; Tanda R
    Contraception; 1999 Jan; 59(1):11-6. PubMed ID: 10342081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate and misoprostol for early abortion in adolescent women.
    Creinin MD; Wiebe E; Gold M
    J Pediatr Adolesc Gynecol; 1999 May; 12(2):71-7. PubMed ID: 10326191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate and misoprostol for early abortion.
    Schaff EA; Eisinger SH; Franks P; Kim SS
    Fam Med; 1996 Mar; 28(3):198-203. PubMed ID: 8900553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of remote and in-clinic follow-up after methotrexate/misoprostol abortion.
    Dunn S; Panjwani D; Gupta M; Meaney C; Morgan R; Feuerstein E
    Contraception; 2015 Sep; 92(3):220-6. PubMed ID: 26068140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conception rates after abortion with methotrexate and misoprostol.
    Creinin MD
    Int J Gynaecol Obstet; 1999 May; 65(2):183-8. PubMed ID: 10405063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone and misoprostol for early abortion when no gestational sac is present.
    Schaff EA; Fielding SL; Eisinger S; Stadalius L
    Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of medical abortion with methotrexate and misoprostol.
    Creinin MD; Park M
    Contraception; 1995 Jul; 52(1):41-4. PubMed ID: 8521713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical abortion with methotrexate 75 mg intramuscularly and vaginal misoprostol.
    Creinin MD
    Contraception; 1997 Dec; 56(6):367-71. PubMed ID: 9494770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion.
    Creinin MD; Potter C; Holovanisin M; Janczukiewicz L; Pymar HC; Schwartz JL; Meyn L
    Am J Obstet Gynecol; 2003 Mar; 188(3):664-9. PubMed ID: 12634638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
    Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
    Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.